These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 22179319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice.
    Gharami K, Xie Y, An JJ, Tonegawa S, Xu B.
    J Neurochem; 2008 Apr; 105(2):369-79. PubMed ID: 18086127
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T, Arbez N, Stewart JC, Chighladze E, Ross CA.
    Cell Cycle; 2015 Apr; 14(11):1716-29. PubMed ID: 25927346
    [Abstract] [Full Text] [Related]

  • 10. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE, Weber JJ, Wlodkowski TT, Yu-Taeger L, Michaud M, Calaminus C, Eckert SH, Gaca J, Weiss A, Magg JC, Jansson EK, Eckert GP, Pichler BJ, Bordet T, Pruss RM, Riess O, Nguyen HP.
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [Abstract] [Full Text] [Related]

  • 11. Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum.
    Grondin R, Kaytor MD, Ai Y, Nelson PT, Thakker DR, Heisel J, Weatherspoon MR, Blum JL, Burright EN, Zhang Z, Kaemmerer WF.
    Brain; 2012 Apr; 135(Pt 4):1197-209. PubMed ID: 22252996
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC, Yusuff T, Cassar M, Thomas E, Kretzschmar D, D'Mello SR.
    J Neurosci; 2017 Jul 05; 37(27):6575-6587. PubMed ID: 28550168
    [Abstract] [Full Text] [Related]

  • 16. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
    Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martín-Ibañez R, Muñoz MT, Mengod G, Ernfors P, Alberch J.
    J Neurosci; 2004 Sep 01; 24(35):7727-39. PubMed ID: 15342740
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.
    Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, Ross CA, Duan W.
    J Neurochem; 2013 May 01; 125(3):410-9. PubMed ID: 23373812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sustained effects of nonallele-specific Huntingtin silencing.
    Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Déglon N.
    Ann Neurol; 2009 Mar 01; 65(3):276-85. PubMed ID: 19334076
    [Abstract] [Full Text] [Related]

  • 20. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.
    Xie Y, Hayden MR, Xu B.
    J Neurosci; 2010 Nov 03; 30(44):14708-18. PubMed ID: 21048129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.